aHeymans Institute of Pharmacology, Ghent University, Ghent, Belgium
bDepartment of Pharmacology and INSERM U970, Hôpital Européen Georges Pompidou, Paris-Descartes University, Paris, France
cCardiovascular Division, Department of Clinical Pharmacology, King's College London British Heart Foundation Centre
dKing's College London, Diabetes, Nutrition and Cardiovascular Divisions, St. Thomas’ Hospital, London, UK
eSecond Department of Internal Medicine, Medical Faculty and University Hospital, Charles University, Pilsen, Czech Republic
fDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
gHypertension Center, 1st Department of Propaedeutic and Internal Medicine, Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece
hUnit of Internal Medicine, Angiology and Arteriosclerotic Disease, University of Perugia Medical School, Hospital 'S. Maria della Misericordia’, Perugia, Italy
iIBiTech-bioMMeda, Ghent University, Ghent, Belgium
jCardiology Department, Klinikum Wels-Grieskirchen, Wels, Austria
Correspondence to Professor Luc M. Van Bortel, MD, PhD, Clinical Pharmacology and Pharmacotherapy, Heymans Institute of Pharmacology, Ghent University, Drug Research Unit Ghent (D.R.U.G.), Ghent University Hospital De Pintelaan 185, 9000 Ghent, Belgium. Tel: +32 9 332 5800; fax: +32 9 332 8959; e-mail: [email protected]
Abbreviation: PWV, pulse wave velocity
Received 11 November, 2011
Accepted 24 November, 2011
